Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.
about
Arachidonic Acid and Cerebral Ischemia Risk: A Systematic Review of Observational StudiesMammalian lipoxygenases and their biological relevanceUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Emerging targets in lipid-based therapyThe leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation.Full and partial agonists of thromboxane prostanoid receptor unveil fine tuning of receptor superactive conformation and G protein activation.Cyclooxygenases 1 and 2 differentially regulate blood pressure and cerebrovascular responses to acute and chronic intermittent hypoxia: implications for sleep apnea.Factors associated with systemic hypertension in asthma.Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.Blood group antigen loci demonstrate multivariate genetic associations with circulating cellular adhesion protein levels in the Multi-Ethnic Study of Atherosclerosis.Thyroxine therapy ameliorates serum levels of eicosanoids in Chinese subclinical hypothyroidism patients.Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenasesMolecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysms.Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acidsAntiplatelet therapy: targeting the TxA2 pathway.Prostanoids and NSAIDs in cardiovascular biology and disease.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Selenium in the prevention of atherosclerosis and its underlying mechanisms.Effects of Olive Oil Phenolic Compounds on Inflammation in the Prevention and Treatment of Coronary Artery Disease.Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages.Protective effects of 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitors on oxidative modification of human low density lipoproteins in vitro.Inflammation, not Cholesterol, Is a Cause of Chronic Disease.Targeted metabolomics reveals altered oxylipin profiles in plasma of mild cognitive impairment patients
P2860
Q26801643-49A71D7C-F603-466E-BA67-4C99B999077BQ28249730-91C6C721-5354-4886-A998-42813A04264DQ28308192-5D171E9B-8680-4F08-9E22-03EDDB977D1DQ28655456-7819940B-830C-4DA8-B90D-BE34941DD3AAQ30234961-DFFE59BC-DA50-412C-9B8D-73C03CB9ABE3Q34389439-67A89BCC-E3C7-43E5-BE7F-D04FD57BDA1EQ34653979-8D1F9CF8-3541-4131-9353-DD24ABAED0B9Q35021937-2204C50F-959E-4271-B4D9-723CBA35F30DQ35976963-938E0829-E5C6-4EB1-B279-C58CDF5780D3Q35995332-2FFA89F2-30D2-4080-877E-22C8941CEB85Q36698082-A9915644-E02C-47C5-8026-477318F507C6Q36872126-34CA4766-440F-4D10-9B49-CDF4DEAFDCF8Q37192356-A347FAD6-6B55-4292-8BAD-FDD8D17D37E4Q37340856-F0D6DF75-4952-4B9C-B26C-6A5DF452420BQ37520764-C21D1ABB-39F3-43FB-A628-171A9C031966Q37619192-016125B5-4A1F-4F71-8F9C-5B2DC75F14C7Q38172461-7FA4755F-FB53-4E9F-9C75-C9E338F89298Q38504675-7A6A1018-5199-4232-BFD4-E2D975BCCE41Q38558587-A1633B12-9CE3-4B74-B00B-EBC3811042C1Q38778791-E53CF61C-D66E-4E3A-AE1F-D8426C514234Q44603423-6043682D-BE8A-4D12-8E96-4ED98F942A2EQ46250023-9E6AD9AC-8271-4814-BF21-A2A0BF298DBEQ46792826-A56D9BA4-9067-42A5-962A-2364C2181789Q55446683-B23FDF1D-FD31-43C0-AE56-8A16AEE87CD9Q59273884-18530963-4150-4EBF-86E0-DE41C3AD7476
P2860
Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Eicosanoids and their drugs in ...... on atherosclerosis and stroke.
@en
Eicosanoids and their drugs in ...... on atherosclerosis and stroke.
@nl
type
label
Eicosanoids and their drugs in ...... on atherosclerosis and stroke.
@en
Eicosanoids and their drugs in ...... on atherosclerosis and stroke.
@nl
prefLabel
Eicosanoids and their drugs in ...... on atherosclerosis and stroke.
@en
Eicosanoids and their drugs in ...... on atherosclerosis and stroke.
@nl
P2860
P50
P356
P1476
Eicosanoids and their drugs in ...... on atherosclerosis and stroke.
@en
P2093
G Enrico Rovati
Marina Camera
P2860
P304
P356
10.1002/MED.21251
P577
2012-03-20T00:00:00Z